Translated automatically – community improvements welcome.
Trifluoperazine
Trifluoperazine is a typical antipsychotic from the group of phenothiazines, primarily acting through its antagonistic effect on dopamine D2 receptors. It is mainly used for the treatment of schizophrenia and other psychotic disorders. Side effects may include extrapyramidal symptoms and sedation. Due to its profile of action, careful medical monitoring is required.
Mechanism of Action
- 5-HT2A antagonist
- D2 receptor antagonist
Names / Identifiers
IUPAC: Trifluoperazine
Mechanism of Action
Trifluoperazin wirkt hauptsächlich als Antagonist an Dopamin-D2-Rezeptoren im zentralen Nervensystem, was zu einer Reduktion von psychotischen Symptomen führt.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Do not use in known hypersensitivity to trifluoperazine.
- Caution in patients with Parkinson's disease.
Known Risks
- medium
- Mögliche Nebenwirkungen umfassen Sedierung, Gewichtszunahme und extrapyramidale Symptome.
Safer Use
- Conduct regular medical check-ups.
- Monitor for side effects and seek medical advice if necessary.
Harm reduction tips do not replace medical advice.
Known Interactions
- May interact with other central nervous system agents.
- Caution when taken concurrently with MAO inhibitors.
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.